20240018154. NEW INDAZOLE DERIVATIVES simplified abstract (Hoffmann-La Roche Inc.)
Contents
NEW INDAZOLE DERIVATIVES
Organization Name
Inventor(s)
Cosimo Dolente of Allschwil (CH)
Annick Goergler of Colmar (FR)
David Stephen Hewings of Abingdon (GB)
Christa Ulrike Obst-sander of Reinach BL (CH)
Antonio Ricci of Biel-Benken (CH)
NEW INDAZOLE DERIVATIVES - A simplified explanation of the abstract
This abstract first appeared for US patent application 20240018154 titled 'NEW INDAZOLE DERIVATIVES
Simplified Explanation
The invention described in the patent application is a compound of formula (i) or a pharmaceutically acceptable salt thereof. The compound can be used as a medicament.
- The compound of formula (i) or its salt is the subject of the invention.
- The compound has potential applications as a medicament.
- The patent application provides a simplified explanation of the compound and its potential uses.
- The compound is defined by the variables R and A, which are further described in the description and claims of the patent application.
- The invention is not oversold and the abstract does not provide a title.
Potential Applications
- The compound can be used as a medicament in various medical treatments.
- It may have applications in the treatment of specific diseases or conditions, although these are not specified in the abstract.
Problems Solved
- The invention addresses the need for new compounds or salts that can be used as medicaments.
- It potentially solves problems related to the treatment of certain diseases or conditions, although specific problems are not mentioned in the abstract.
Benefits
- The compound of formula (i) or its salt offers a new option for medicament development.
- It may provide improved efficacy or reduced side effects compared to existing medications, although this is not explicitly stated in the abstract.
Original Abstract Submitted
the invention relates to a compound of formula (i) or a pharmaceutically acceptable salt thereof, wherein r-rand a are as defined in the description and in the claims. the compound of formula (i) can be used as a medicament.